These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32052244)
1. HCV infection and non-Hodgkin lymphomas: an evolving story. Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244 [TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. Merli M; Carli G; Arcaini L; Visco C World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957 [TBL] [Abstract][Full Text] [Related]
3. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma. Mihăilă RG World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211 [TBL] [Abstract][Full Text] [Related]
5. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents. Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy. Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885 [TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of HCV-associated B-Cell Non-Hodgkin Lymphomas With Direct-acting Antiviral Agents. de Clerck F; Geerts A; Brochez L; Speeckaert R; Boterberg T; Van Vlierberghe H; Verhelst X J Clin Gastroenterol; 2016; 50(5):438. PubMed ID: 26905607 [No Abstract] [Full Text] [Related]
8. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Kelaidi C; Rollot F; Park S; Tulliez M; Christoforov B; Calmus Y; Podevin P; Bouscary D; Sogni P; Blanche P; Dreyfus F Leukemia; 2004 Oct; 18(10):1711-6. PubMed ID: 15284859 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. Arcaini L; Bruno R Curr Clin Pharmacol; 2010 May; 5(2):74-81. PubMed ID: 20156155 [TBL] [Abstract][Full Text] [Related]
10. Antiviral therapies for managing viral hepatitis in lymphoma patients. Merli M; Rattotti S; Gotti M; Arcaini L Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment. Visco C; Finotto S World J Gastroenterol; 2014 Aug; 20(32):11054-61. PubMed ID: 25170194 [TBL] [Abstract][Full Text] [Related]
12. From hepatitis C virus infection to B-cell lymphoma. Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus - Associated marginal zone lymphoma. Armand M; Besson C; Hermine O; Davi F Best Pract Res Clin Haematol; 2017; 30(1-2):41-49. PubMed ID: 28288715 [TBL] [Abstract][Full Text] [Related]
15. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy. Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334 [TBL] [Abstract][Full Text] [Related]
16. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Arcaini L; Vallisa D; Rattotti S; Ferretti VV; Ferreri AJM; Bernuzzi P; Merli M; Varettoni M; Chiappella A; Ambrosetti A; Tucci A; Rusconi C; Visco C; Spina M; Cabras G; Luminari S; Tucci M; Musto P; Ladetto M; Merli F; Stelitano C; d'Arco A; Rigacci L; Levis A; Rossi D; Spedini P; Mancuso S; Marino D; Bruno R; Baldini L; Pulsoni A Ann Oncol; 2014 Jul; 25(7):1404-1410. PubMed ID: 24799461 [TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin lymphoma and hepatitis C: where we are and what next? Sulyok M; Makara M; Újhelyi E; Vályi-Nagy I Pathol Oncol Res; 2015 Jan; 21(1):1-7. PubMed ID: 25273531 [TBL] [Abstract][Full Text] [Related]
18. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis. Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and lymphoma. Paydas S Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774 [TBL] [Abstract][Full Text] [Related]
20. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. Hermine O; Lefrère F; Bronowicki JP; Mariette X; Jondeau K; Eclache-Saudreau V; Delmas B; Valensi F; Cacoub P; Brechot C; Varet B; Troussard X N Engl J Med; 2002 Jul; 347(2):89-94. PubMed ID: 12110736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]